Study number 8529-369
Screening Appointments Available!
Dates
Jan 13 2025-Feb 11 2025
Location
Daytona Beach, Florida
Age
18-60
Gender
Male or Female
Compensation
$5,032
Group
3a OR 3b
Study Details
The investigational drug in this research study is being developed for the treatment of a type of peripheral nerve disease called Chronic Inflammatory Demyelinating Polyneuropathy, a disorder that involves progressive weakness and reduced senses in the arms and legs.
Fortrea Daytona Beach, FL is recruiting for:
- Healthy Non-Smoking Men and Women, Age 18-60
- Body Mass Index between 18-32
- Study involves 2 separate stays totaling 6 nights, 4 follow-up visits, and 4 phone calls
- Compensation up to $5,032 may be provided for time and participation
- Refer a friend to receive $300 per qualified referral
Additional Details
Call now to schedule your screening appointment.
Group 3a:
Check-in: Jan 13
Check-out: Jan 18
Phone Call: Jan 19 & 20
Check-in: Jan 21
Check-out: Jan 22
Phone Call: Jan 23 & 25
Follow up visits: Jan 24, 28, Feb 4, 11
OR
Group 3b:
Check-in: Jan 22
Check-out: Jan 27
Phone Call: Jan 28 & 29
Check-in: Jan 30
Check-out: Jan 31
Phone Call: Feb 1 & 3
Follow up visits: Feb 2, 6, 13, 20